China impulsa la innovación en oncología.
📊 Descubre en este póster 5 medicamentos innovadores para el cáncer de mama.

#CáncerDeMama #Dalpiciclib #Pyrotinib #Chidamide #Envafolimab #DisitamabVedotin #HER2 #HER2Positive #TargetedTherapy #ADC #TerapiasInnovadoras #DengYueMedicinasEnHongKong

Triple HER2 Blockade With Trastuzumab, Pertuzumab, and Pyrotinib Versus Dual HER2 Blockade in the Neoadjuvant Treatment of HER2‐Positive Breast Cancer: A Randomized, Phase II Study Triple HER2 blockade with trastuzumab, pertuzumab, and pyrotinib (TPPy) did not improve total pathological complete response (tpCR) rates or breast pathological complete response (bpCR) rates compare....

#Article in @MedComm_MC
Triple #HER2 Blockade With #Trastuzumab, #Pertuzumab, and #Pyrotinib Versus Dual HER2 Blockade in the #Neoadjuvant Treatment of HER2-Positive Breast Cancer: A Randomized, Phase II Study doi.org/10.1002/mco2...

#ClinicalTrial

#TDM1 is effective and safe for metastatic #HER2PositiveBreastCancer after #pyrotinib and/or trastuzumab–pertuzumab failure, with low cancer cell cycle activity and activated macrophages/CD8⁺ T cells predicting treatment response.

#OpenAccess in #STTT: doi.org/10.1038/s413...

Evaluation of the efficacy & safety of adding #Pyrotinib to a #neoadjuvant regimen of #Trastuzumab & #chemotherapy in HER2-positive #BreastCancer patients showed that pyrotinib elicits a beneficial response. #medsky

#STTT #OpenAccess: doi.org/10.1038/s413...